Summit Therapeutics Appoints Ankur Dhingra as Chief Financial Officer
globenewswire.com
news
2022-06-01 00:00:00

Cambridge, MA, June 01, 2022 (GLOBE NEWSWIRE) -- Summit Therapeutics Inc. (NASDAQ: SMMT) today announced that Ankur DhingraÂ has been appointed as Chief Financial Officer, effective immediately. 'We are in a pivotal time for Team Summit as we seek to expand our portfolio of pipeline assets through potential collaborations and possible acquisitions,' said Robert W. Duggan, Chairman and Chief Executive Officer of Summit. 'Ankur's leadership and experience will be critical in ensuring the financial viability and excellence of our organization.
